Laurent Grandidier is the founder of Xeltis. Xeltis has raised $119M in total funding. Latest round: Series C. Backed by Ysios Capital, LSP, Kurma Partners.
Laurent Grandidier is the Chief Executive Officer of Xeltis, a biomedical technology company that develops autologous growing, living, and self-healing cardiovascular implants using tissue-engineering technology. Xeltis, founded in 2006 as a spin-off of the University of Zurich, focuses on creating heart valve technology with growth, longevity, and self-healing properties. Prior to joining Xeltis, Grandidier was the Vice President of Sales and Marketing for Endosense and held international executive positions at Teleflex Medical, Boston Scientific, Guidant, and Procter & Gamble.
Full founder directory · Investor directory · Company funding database · Fundraising library